Table 2.
Cell Viability Rate of Treated Caco-2 Cells
| Treatment | Concentration (mg/ml) | Mean Absorbance (570nm) | P-values | ||
|---|---|---|---|---|---|
| NCM-460 cells | Caco-2 cells | NCM-460 cells | Caco-2 cells | ||
| Asp | 0.0¥ | 0.57±0.1 | 0.57±0.1 | ||
| 1.25 | 0.70±0.06 | 0.70±0.06 | > 0.05 | > 0.05 | |
| 2.5 | 0.80±0.11 | 0.84± 0.11 | < 0.05* | < 0.05* | |
| 5 | 0.74±0.1 | 0.89± 0.08 | < 0.05* | < 0.01** | |
| 10 | 0.86±0.08 | 0.89± 0.06 | < 0.01** | < 0.01** | |
| 20 | 0.89±0.07 | 1.01± 0.02 | < 0.01** | < 0.01** | |
| NNDAsp | 0.0¥ | 0.65±0.13 | 0.6± 0.13 | ||
| 1.25 | 0.58±0.1 | 0.60± 0.13 | > 0.05 | > 0.05 | |
| 2.5 | 0.5±0.1 | 0.48± 0.13 | > 0.05 | > 0.05 | |
| 5 | 0.54±0.08 | 0.23± 0.1 | > 0.05 | < 0.01** | |
| 10 | 0.64±0.13 | 0.12± 0.1 | > 0.05 | < 0.01** | |
| 20 | 0.74±0.13 | 0.08± 0.02 | > 0.05 | < 0.01** | |
¥, DMSO; *, Indicates significant P values ≤ 0.05; **, Indicates high significant P values ≤0.01